ADHD Online, MD-Led Platform

ADHD Online is a telehealth platform launched to close the gap between the growing demand for ADHD diagnosis in adults and the limited supply of psychiatrists and psychologists willing to see new patients for evaluations. The platform offers structured, video-based ADHD assessments and ongoing treatment packages across 40 states, serving adults who have suspected ADHD for years but have been unable to access an evaluation through traditional healthcare channels. The assessment process uses a validated online questionnaire followed by a live video appointment with a licensed clinician — a psychiatrist, psychologist, or psychiatric nurse practitioner depending on the state. ADHD Online's evaluation is not a traditional neuropsychological battery (which involves hours of standardized testing), but rather a clinical interview and symptom assessment designed to reach a diagnostic conclusion appropriate for prescribing purposes. Patients who receive a diagnosis get an official letter they can share with other providers or use for workplace accommodations. Ongoing care is structured as a 12-month treatment program covering five visits: the initial evaluation, a 30-day check-in, and quarterly medication management appointments at three, six, and nine months. This package format gives patients a clear treatment timeline and limits the open-ended accumulation of per-session costs. Between visits, providers are accessible through the platform's secure messaging feature. ADHD Online does not bill insurance directly, but provides itemized superbills after each visit that patients can submit to their insurer for out-of-network reimbursement. Many commercial insurance plans reimburse 60–100% of out-of-network psychiatry costs, depending on the plan's OON benefits. The cash-pay rates ($199 initial, $175 follow-up) are meaningfully below typical in-person psychiatry rates while still capturing most of the clinical value. Stimulant prescribing is available in many states where ADHD Online operates, though availability is subject to provider and state regulations — patients in states with more restrictive telehealth prescribing rules may find non-stimulant options are the only pathway available. ADHD Online currently operates in 40 states. The platform offers structured, video-based ADHD assessments and ongoing treatment packages across 40 states, serving adults who have suspected ADHD for years but have been unable to access an evaluation through traditional healthcare channels. The assessment process uses a validated online questionnaire followed by a live video appointment with a licensed clinician — a psychiatrist, psychologist, or psychiatric nurse practitioner depending on the state. ADHD Online's evaluation is not a traditional neuropsychological battery (which involves hours of standardized testing), but rather a clinical interview and symptom assessment designed to reach a diagnostic conclusion appropriate for prescribing purposes. Patients who receive a diagnosis get an official letter they can share with other providers or use for workplace accommodations. Ongoing care is structured as a 12-month treatment program covering five visits: the initial evaluation, a 30-day check-in, and quarterly medication management appointments at three, six, and nine months. This package format gives patients a clear treatment timeline and limits the open-ended accumulation of per-session costs. Between visits, providers are accessible through the platform's secure messaging feature. ADHD Online does not bill insurance directly, but provides itemized superbills after each visit that patients can submit to their insurer for out-of-network reimbursement. Many commercial insurance plans reimburse 60–100% of out-of-network psychiatry costs, depending on the plan's OON benefits. The cash-pay rates ($199 initial, $175 follow-up) are meaningfully below typical in-person psychiatry rates while still capturing most of the clinical value. Stimulant prescribing is available in many states where ADHD Online operates, though availability is subject to provider and state regulations — patients in states with more restrictive telehealth prescribing rules may find non-stimulant options are the only pathway available. ADHD Online currently operates in 40 states.